Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | June 2010 |
End Date: | August 2013 |
Contact: | Chris E Holmes, MD, PhD |
Email: | ceholmes@uvm.edu |
Phone: | 802-656-0302 |
Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and
coagulation proteins.
coagulation proteins.
Inclusion Criteria:
- Patients with a diagnosis of malignancy
Exclusion Criteria:
- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
We found this trial at
1
site
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)